Cargando…
Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome
OBJECTIVE: Polycystic ovarian syndrome is the most common cause of infertility and endocrine disorder among women due to anovulation. The aim of the present study is to investigate the effect of chamomile on oligomenorrhea and hirsutism symptoms as well as hormonal parameters among patients sufferin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350545/ https://www.ncbi.nlm.nih.gov/pubmed/37465426 http://dx.doi.org/10.18502/jfrh.v16i4.11355 |
_version_ | 1785074157597229056 |
---|---|
author | Afiat, Malihe Akbari Lor, Azam Najaf Najafi, Mona Ghazanfarpour, Masumeh Jafarabadi, Mina |
author_facet | Afiat, Malihe Akbari Lor, Azam Najaf Najafi, Mona Ghazanfarpour, Masumeh Jafarabadi, Mina |
author_sort | Afiat, Malihe |
collection | PubMed |
description | OBJECTIVE: Polycystic ovarian syndrome is the most common cause of infertility and endocrine disorder among women due to anovulation. The aim of the present study is to investigate the effect of chamomile on oligomenorrhea and hirsutism symptoms as well as hormonal parameters among patients suffering from polycystic ovarian syndrome. MATERIALS AND METHODS: The present study is a randomized clinical trial performed on 70 patients with diagnosis of polycystic ovarian syndrome according to Rotterdam criteria referring to the infertility clinic of a university hospital. The patients were randomly assigned into intervention and control groups, with the former receiving two chamomile capsules 500 mg for three months, and the latter receiving two placebo capsules for 3 months. Both groups were evaluated in terms of laboratory parameters (FBS, LDL, and testosterone) on the third day of first and third cycles. The collected data were analyzed by SPSS 20. RESULTS: The mean age, body mass index, marital status, history of infertility, and pregnancy rate showed no significant difference between the two groups. In the chamomile group, clinical symptoms of hirsutism (p<0.001) and oligomenorrhea (p=0.048) decreased following the treatment, but significant difference was found between the two groups only in hirsutism symptoms (p=0.028). Regarding the parameters of FBS (p=0.06), HDL (p=0.224), cholesterol (p=0.99), triglyceride (p=0.106), testosterone (p=0.894), and LDL (p=0.61), no significant difference was observed between the two groups. Nevertheless, following the treatment, testosterone decreased in both placebo (p=0.005) and chamomile (p=0.001) groups. CONCLUSION: overall, the chamomile therapeutic regimen has relatively been able to mitigate the clinical symptoms and testosterone levels in patients suffering from polycystic ovarian syndrome. Use of chamomile plant as a simple, inexpensive, and effective measure can be suggested for improving and treating patients with PCOS after confirmation by further studies. |
format | Online Article Text |
id | pubmed-10350545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-103505452023-07-18 Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome Afiat, Malihe Akbari Lor, Azam Najaf Najafi, Mona Ghazanfarpour, Masumeh Jafarabadi, Mina J Family Reprod Health Original Article OBJECTIVE: Polycystic ovarian syndrome is the most common cause of infertility and endocrine disorder among women due to anovulation. The aim of the present study is to investigate the effect of chamomile on oligomenorrhea and hirsutism symptoms as well as hormonal parameters among patients suffering from polycystic ovarian syndrome. MATERIALS AND METHODS: The present study is a randomized clinical trial performed on 70 patients with diagnosis of polycystic ovarian syndrome according to Rotterdam criteria referring to the infertility clinic of a university hospital. The patients were randomly assigned into intervention and control groups, with the former receiving two chamomile capsules 500 mg for three months, and the latter receiving two placebo capsules for 3 months. Both groups were evaluated in terms of laboratory parameters (FBS, LDL, and testosterone) on the third day of first and third cycles. The collected data were analyzed by SPSS 20. RESULTS: The mean age, body mass index, marital status, history of infertility, and pregnancy rate showed no significant difference between the two groups. In the chamomile group, clinical symptoms of hirsutism (p<0.001) and oligomenorrhea (p=0.048) decreased following the treatment, but significant difference was found between the two groups only in hirsutism symptoms (p=0.028). Regarding the parameters of FBS (p=0.06), HDL (p=0.224), cholesterol (p=0.99), triglyceride (p=0.106), testosterone (p=0.894), and LDL (p=0.61), no significant difference was observed between the two groups. Nevertheless, following the treatment, testosterone decreased in both placebo (p=0.005) and chamomile (p=0.001) groups. CONCLUSION: overall, the chamomile therapeutic regimen has relatively been able to mitigate the clinical symptoms and testosterone levels in patients suffering from polycystic ovarian syndrome. Use of chamomile plant as a simple, inexpensive, and effective measure can be suggested for improving and treating patients with PCOS after confirmation by further studies. Tehran University of Medical Sciences 2022-12 /pmc/articles/PMC10350545/ /pubmed/37465426 http://dx.doi.org/10.18502/jfrh.v16i4.11355 Text en Copyright © 2022 Tehran University of Medical Sciences. Published by Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Afiat, Malihe Akbari Lor, Azam Najaf Najafi, Mona Ghazanfarpour, Masumeh Jafarabadi, Mina Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title | Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title_full | Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title_fullStr | Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title_full_unstemmed | Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title_short | Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome |
title_sort | examining the effect of chamomile on clinical symptoms and hormonal parameters among patients with polycystic ovarian syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350545/ https://www.ncbi.nlm.nih.gov/pubmed/37465426 http://dx.doi.org/10.18502/jfrh.v16i4.11355 |
work_keys_str_mv | AT afiatmalihe examiningtheeffectofchamomileonclinicalsymptomsandhormonalparametersamongpatientswithpolycysticovariansyndrome AT akbarilorazam examiningtheeffectofchamomileonclinicalsymptomsandhormonalparametersamongpatientswithpolycysticovariansyndrome AT najafnajafimona examiningtheeffectofchamomileonclinicalsymptomsandhormonalparametersamongpatientswithpolycysticovariansyndrome AT ghazanfarpourmasumeh examiningtheeffectofchamomileonclinicalsymptomsandhormonalparametersamongpatientswithpolycysticovariansyndrome AT jafarabadimina examiningtheeffectofchamomileonclinicalsymptomsandhormonalparametersamongpatientswithpolycysticovariansyndrome |